Featured
- Get link
- X
- Other Apps
Avian Influenza Vaccine Market Size, Share, Demand, Growth, Application, Analysis and Industry Forecast to 2032
The Avian Influenza Vaccine market is anticipated to
reach USD 1.18 Billion 2032 at a CAGR 7.5% during the forecast period
2023-2032.
The Avian Influenza Vaccine Market is
witnessing robust growth due to heightened awareness of avian influenza
outbreaks globally. With the threat of avian flu strains like H5N1 and H7N9,
the market for avian influenza vaccines has expanded significantly. Rising
poultry production and consumption, coupled with stringent government
regulations on poultry health, are key drivers. Major pharmaceutical companies
are investing in research and development to enhance vaccine efficacy and
broaden coverage against diverse avian flu strains. Additionally, increasing
collaborations between research institutions and vaccine manufacturers are
fostering innovation. The market is poised for steady growth as stakeholders
prioritize preventive measures against avian influenza outbreaks.
The Avian Influenza Vaccine Market is
witnessing significant growth due to rising concerns about avian flu outbreaks
among poultry populations worldwide. Avian flu, caused by the highly pathogenic
avian influenza (HPAI) virus strains such as H5N1, poses a severe threat to
both animal health and global food security. As a result, the demand for avian
flu vaccines, particularly for poultry, has surged in recent years.
Avian flu vaccines for poultry play a
crucial role in preventing the spread of the HPAI virus and minimizing economic
losses for the poultry industry. These vaccines are specifically formulated to
provide effective protection against prevalent strains like H5N1, which can
devastate poultry populations and pose potential risks to human health.
The market for avian flu vaccines encompasses
a range of products tailored to different poultry species and production
systems. Manufacturers continually innovate to develop more efficacious and
cost-effective vaccines to meet the evolving needs of poultry producers
worldwide.
With the increasing adoption of
vaccination programs and stringent regulations governing poultry health
management, the avian influenza vaccine market is poised for steady growth.
Poultry producers, government agencies, and veterinary professionals recognize
the importance of proactive measures such as vaccination to mitigate the risk
of avian flu outbreaks and safeguard both animal welfare and public health.
Market Segmentation
The MRFR report offers an inclusive segmental
analysis of the global avian influenza vaccine market report by application
& strain.
Based on strain, the avian influenza vaccine market
has been segmented into H5, H7, & H9. Among these, the H5 segment will lead
the market over the forecast period as it is the most commonly used.
Based on application, the avian influenza vaccine
market has been segmented into goose, turkey, chicken, and duck. Of these, the
chicken segment will dominate the market over the forecast period over the
forecast period.
Regional Analysis
Based on the region, the avian influenza vaccine
market report covers the recent trends and growth opportunities across the
Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa
(MEA). Of these, both the Middle East and APAC will spearhead the market over
the forecast period. Factors boosting the avian influenza vaccine market growth
in the region include numerous initiatives by the government for effective and
rapid avian influenza management in the region coupled with an increase in avian
influenza outbreaks. Besides, the increasing research and development
expenditure by several key players in the region is also adding market
growth.
In Europe, the avian influenza vaccine market is
predicted to hold the second-largest share over the forecast period for private
entities and collaborative initiatives by the government for promoting improved
animal health coupled with rising production of veterinary products. The EU is closely
working together with the World Organization for Animal Health, the Food and
Agriculture Organization, and the World Health Organization in response to the
worldwide threat of avian flu.
Key Players
The global avian
influenza vaccine companies are Avimex Animal
Health (Mexico), QYH BIOTECH COMPANY LIMITED (China), Guangdong Wenshi
Dahuanong Biotechnology Co., Ltd (China), JOVAC (Jordan), PT Japfa Comfeed
Indonesia Tbk (Indonesia), Medion (Indonesia), Merck Animal Health (US),
Chengdu Tech-bank Biological Products Co., Ltd (China), FATRO S.P.A. (Italy),
Yebio Bioengineering Co., Ltd (China),Tianjin Ringpu Bio-Technology Co., Ltd
(China), CAVAC (South Korea), Zoetis (US), Ceva (US), and Boehringer Ingelheim
International GmbH (Germany).
Related Report:
Liquid Chromatography Instruments
For More Information, Please Visit @ Market Research Future
Popular Posts
Regulatory Framework and Market Entry Strategies in the North America Spine Biologics Market: A Comparative Analysis
- Get link
- X
- Other Apps
Thyroid Test Market By Medical Scopes, Laboratories Research, Growth And Top Companies Analysis 2032
- Get link
- X
- Other Apps

Comments
Post a Comment